about
Progesterone and Overlooked Endocrine Pathways in Breast Cancer PathogenesisInfection and cancer in multicellular organismsUltrasonographic evaluation of depth-width ratio (D/W) of benign and malignant mammary tumors in dogs.The role of SET/I2PP2A in canine mammary tumors.Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer.Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.First pathological study of canine primary breast lymphoma and the description of its clinicopathological characteristics as an animal model for human primary breast lymphoma.Genome aberrations in canine mammary carcinomas and their detection in cell-free plasma DNA.Pilot study of p62 DNA vaccine in dogs with mammary tumorsPrevalence of the Prefoldin Subunit 5 Gene Deletion in Canine Mammary Tumors.The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study.Gabapentin as an adjuvant for postoperative pain management in dogs undergoing mastectomy.Hormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples.Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index.A first immunohistochemistry study of transketolase and transketolase-like 1 expression in canine hyperplastic and neoplastic mammary lesions.Effectiveness of CO2 laser in an experimental mammary gland adenocarcinoma model.Development of new therapy for canine mammary cancer with recombinant measles virus.Assessment of postoperative pain after unilateral mastectomy using two different surgical techniques in dogs.Use of the optical disector in canine mammary simple and complex carcinomas.Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds.Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT.Histopathologic findings in uterus and ovaries collected from clinically healthy dogs at elective ovariohysterectomy: a cross-sectional StudyCanine mammary carcinomas: influence of histological grade, vascular invasion, proliferation, microvessel density and VEGFR2 expression on lymph node status and survival time.Botulinum toxin type A as an adjunct in postoperative pain management in dogs undergoing radical mastectomy.A three-dimensional cell culture system as an in vitro canine mammary carcinoma model for the expression of connective tissue modulators.Salinomycin inhibits canine mammary carcinoma in vitro by targeting cancer stem cellsBiochemical characterization of variants of canine CYP1A1 using heterologous expression.Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression.In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.Clinicopathological Diversity of Canine Mammary Gland Tumors in Sri Lanka: A One-Year Survey on Cases Presented to Two Veterinary Practices.Over-expression of PTEN on proliferation and apoptosis in canine mammary tumors cellsCombination of Suicide and Cytokine Gene Therapies as Surgery Adjuvant for Canine Mammary Carcinoma
P2860
Q26799158-02C53D3F-35DC-4581-9027-A45B69F329D9Q26863592-848D860B-5BA9-4829-987A-5D5719E25BBEQ30385968-80D37BB2-B627-411F-8F27-107D091547C7Q33842870-41D99507-9BDA-41B0-BAAA-9FBE108A1A76Q34205235-14ED8480-C501-4D94-B84F-D0C3AE9EEC6AQ34333126-ED9A436E-7E8A-40D9-AE51-C56D81F7056DQ34607482-A9276FCF-43DF-4AFF-A14E-3EA08B4F92EFQ35010017-A6D15D53-9730-48E4-8991-D9E3E2627AD9Q35149622-83525F32-5362-4A36-B424-421033AAF592Q35680289-CF6852C7-CE46-4388-9925-0CB8816729A1Q35790286-9D4A51FF-96A7-462E-B4E6-28ABBDDAC956Q36048300-10FC7B58-C154-4D78-B177-E57EEE2C2033Q36138577-9A86DA9F-77A1-4474-B3EB-98380150B0E8Q36247593-A306C437-899A-48C6-A702-C392AA7C3C69Q36265702-4AAAC793-7D67-4606-B9B6-C00A971C35A0Q36332693-E081CB43-586D-4B22-9F2D-42657DE323FEQ36664263-284A14DE-58A0-412B-AE07-CF80C6B00F0EQ37116910-AEBB9F76-1323-47E8-ACE2-0AB562E21F40Q38674224-49461CD8-07EA-4EC4-BCC6-DAAE503623BFQ38718417-822EC2C7-A417-4B0F-91EB-556726A8A365Q38773516-5B9EAAA4-C97F-4641-9415-8A31DA37E95BQ39498468-0DCF236B-CFC3-4E29-888F-136623A9768DQ40034698-184B5FB7-6CE3-42E6-BC78-27BE62F2DE1BQ40455025-33D0923B-6EAC-4872-B787-AEC92F9227CDQ40845711-21760920-3A86-4AC4-B667-D6D0A5F04B3EQ40977870-A3A863C9-65D8-4AE0-8D31-1A59DDD185D1Q41538504-46BBD269-EE5A-4E12-81B7-42284645AEF8Q43123105-82EEFFB7-BEA9-42C0-B21C-136BA8EA9B01Q47664161-F7F0FE69-F7BC-48E4-9AE0-833F9DA32460Q52558390-9C477532-39CD-42E4-8A5C-B6FD1D17C155Q58134027-12341532-C0D0-4256-ADE9-3035C464E392Q58800776-0839F625-F051-4924-9B09-D24B65CFEBCD
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Canine mammary tumours, an overview.
@en
Canine mammary tumours, an overview.
@nl
type
label
Canine mammary tumours, an overview.
@en
Canine mammary tumours, an overview.
@nl
prefLabel
Canine mammary tumours, an overview.
@en
Canine mammary tumours, an overview.
@nl
P2093
P2860
P1476
Canine mammary tumours, an overview.
@en
P2093
C Van Ginneken
E J B Veldhuis Kroeze
H de Rooster
L Van Brantegem
P2860
P304
P356
10.1111/J.1439-0531.2011.01816.X
P577
2011-06-06T00:00:00Z